Neuro-Oncology

Oxford University Press

Evaluation status available after sign-in

About the journal

Neuro-Oncology is a journal published by Oxford University Press in United States. It is listed in MEDLINE and PUBMED according to the sources read. Declared publication charge: 4,612 USD. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Oxford University Press
ISSN
1522-8517 · 1523-5866
Country
United States
Access
Not open access / not declared
Declared publication charge
4,612 USD

Index listings

  • MEDLINE · 1999-01-01
  • PUBMED · 2016-10-01
Indexing
MEDLINE · PUBMED
APC
4,612 USD
Declared review time (DOAJ)
—
Actual review time (measured)
114 days received→accepted — computed from PubMed (n=97)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

29943

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

217

i10-index

3099

From OpenAlex open data (CC0).

Editorial & policy5
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Norwegian register (HK-dir)— 2027
Level 2 — top tier (~20% of the field's channels)
Open references deposited at Crossref
11%
ORCID iDs in current deposits
11%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
Identity & continuity3
Alternate titles
Neuro oncology
Source type
journal
NLM unique ID (PubMed)
100887420
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Glioma Diagnosis and Treatment
  • Glioma Diagnosis and Treatment
  • Brain Metastases and Treatment
  • Brain Metastases and Treatment
  • Radiomics and Machine Learning in Medical Imaging
  • Radiomics and Machine Learning in Medical Imaging
  • Cancer, Hypoxia, and Metabolism
  • Cancer, Hypoxia, and Metabolism
Show all subjects (50)
  • Meningioma and schwannoma management
  • Meningioma and schwannoma management
  • Neuroblastoma Research and Treatments
  • Neuroblastoma Research and Treatments
  • Cancer Research and Treatments
  • Cancer Research and Treatments
  • CAR-T cell therapy research
  • CAR-T cell therapy research
  • Cancer Genomics and Diagnostics
  • Cancer Genomics and Diagnostics
  • Neurofibromatosis and Schwannoma Cases
  • Neurofibromatosis and Schwannoma Cases
  • Ferroptosis and cancer prognosis
  • Ferroptosis and cancer prognosis
  • Cancer Treatment and Pharmacology
  • Cancer Treatment and Pharmacology
  • Cancer Immunotherapy and Biomarkers
  • Cancer Immunotherapy and Biomarkers
  • Radiopharmaceutical Chemistry and Applications
  • Radiopharmaceutical Chemistry and Applications
  • Epigenetics and DNA Methylation
  • Epigenetics and DNA Methylation
  • Immune cells in cancer
  • Nanoplatforms for cancer theranostics
  • Immune cells in cancer
  • Nanoplatforms for cancer theranostics
  • Immunotherapy and Immune Responses
  • Immunotherapy and Immune Responses
  • Medical Imaging Techniques and Applications
  • Medical Imaging Techniques and Applications
  • MRI in cancer diagnosis
  • Chromatin Remodeling and Cancer
  • Chromatin Remodeling and Cancer
  • MRI in cancer diagnosis
  • Protein Degradation and Inhibitors
  • Protein Degradation and Inhibitors
  • Cancer-related cognitive impairment studies
  • Cancer-related cognitive impairment studies
  • Microtubule and mitosis dynamics
  • Microtubule and mitosis dynamics
  • Cancer Cells and Metastasis
  • Cancer Cells and Metastasis

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: